On Friday, British drugmaker GSK (NYSE: GSK) said it would seek a dismissal of an upcoming Zantac case in Florida, […]
GSK (NYSE: GSK) to Seek Dismissal of Florida Zantac Case Over Prostate Cancer Claims Read More »
FRANKFURT – On Thursday, Germany’s influential vaccine advisory panel said that everyone in the country who is 75 years old
German Panel Endorses GSK, Pfizer RSV Vaccines for 75+ Age Group Read More »
GSK (NYSE: GSK) won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on
GSK (NYSE: GSK) Scores Legal Win as Zantac Cancer Claims Falter Read More »
British drugmaker GSK (NYSE: GSK) cut its forecast for 2024 vaccine sales on Wednesday after quarterly revenue from its blockbuster
GSK (NYSE: GSK) Lowers 2024 Vaccine Sales Forecast, Stock Falls Read More »
On Wednesday, British drugmaker GSK (NYSE: GSK) bought partner CureVac (NASDAQ: CVAC) out of their alliance on influenza and COVID-19
GSK (NYSE: GSK) Acquires Full Rights to COVID and Influenza Vaccines from CureVac Read More »
GSK shares (NYSE: GSK) fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed
GSK (NYSE: GSK) Stock Slumps as US Health Agency Alters RSV Vaccine Advice Read More »
GSK plc (NYSE: GSK), a British drugmaker, has agreed to settle a lawsuit in the United States regarding its discontinued
GSK’s Best Day of the Year: Shares Rise Amid Zantac Lawsuit Settlement Read More »
